CSIMarket
 
Iqvia Holdings Inc   (NYSE: IQV)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $267.7700 $-3.85 -1.417%
Day's High: $271.7998962402344 Week Perf: 2.52 %
Day's Low: $ 262.60 30 Day Perf: 15.2 %
Volume (M): 1,151,786 52 Wk High: $ 271.80
Volume (M$): $ 0 52 Wk Avg: $202.11
Open: $268.48 52 Wk Low: $154.50



 Market Capitalization (Millions $) 45,467
 Shares Outstanding (Millions) 170
 Employees 93,000
 Revenues (TTM) (Millions $) 16,632
 Net Income (TTM) (Millions $) 1,387
 Cash Flow (TTM) (Millions $) 207
 Capital Exp. (TTM) (Millions $) 588

Business Description


IQVIA Holdings Inc. Overview

IQVIA Holdings Inc. is a prominent global provider of innovative solutions and services tailored to the biopharmaceutical and healthcare industries. The company was established through the merger of two key players in the industry: Quintiles, well-regarded for its clinical research capabilities, and IMS Health, known for its expertise in healthcare data and analytics. The firms headquarters are located in Durham, North Carolina, and it operates in over 100 countries worldwide.

Core Services and Expertise

IQVIA is recognized as a leading provider of clinical trial services. Its offerings encompass:

- Clinical Research and Development: Comprehensive support for the phases of drug development.
- Clinical Trial Execution: Efficient management and execution of trials to ensure compliance and quality.
- Data Management: Robust systems for collecting, managing, and analyzing clinical data.
- Patient Recruitment: Strategic approaches to identify and enroll participants effectively for clinical trials.

Alongside clinical services, IQVIA provides a variety of commercial solutions, including:

- Market Research: Insights into market dynamics and consumer behavior.
- Sales and Marketing Effectiveness: Strategies and tools to enhance the effectiveness of sales and marketing efforts.
- Commercial Operations: Comprehensive support for the operational side of product commercialization.

Data Assets and Insights

IQVIA boasts an extensive portfolio of proprietary data assets, including one of the largest healthcare databases globally, which encompasses over 1 billion patient records. This extensive data enables IQVIA to deliver critical insights into healthcare trends, identify suitable patient populations for clinical studies, and assist clients in making informed decisions surrounding product development and market entry.

Clientele

The companys diverse client base includes:

- Pharmaceutical and biotechnology companies
- Medical device manufacturers
- Healthcare providers
- Payers (insurance companies)
- Government agencies

IQVIA collaborates closely with these clients to help them devise and implement innovative solutions that improve healthcare outcomes.

Corporate Social Responsibility

Beyond its core business, IQVIA actively engages in several social responsibility initiatives. These include:

- Addressing health disparities
- Promoting diversity and inclusion within the workplace
- Supporting underserved communities across the globe

Through these initiatives, the company aims to make a meaningful impact on public health and healthcare equity.

Workforce and Culture

IQVIA employs around 67,000 professionals, many of whom are highly skilled in various domains, including science, clinical practice, and data analysis. The companys workplace culture emphasizes innovation, collaboration, and continuous learning, ensuring that employees are well-equipped with the necessary skills and resources to contribute positively to healthcare globally. IQVIA is dedicated to developing its workforce while fostering an environment that encourages growth and professional development.

In summary, IQVIA Holdings Inc. stands out as a vital player in the healthcare landscape, combining extensive data resources and clinical expertise to support the advancement of biopharmaceutical innovations and healthcare solutions worldwide.


   Company Address: 2400 Ellis Rd. Durham 27703 NC
   Company Phone Number: 998-2000   Stock Exchange / Ticker: NYSE IQV


Customers Net Income grew by IQV's Customers Net Profit Margin grew to

76.65 %

16.67 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CRL   -1.03%    
LH   -2.45%    
MEDP   -1.56%    
NOTV      0% 
NRC   -1.46%    
CMCSA   -2.11%    
• View Complete Report
   



Business Update

IQVIA Pioneering AI Breakthroughs in Healthcare Excellence,

Published Mon, Feb 24 2025 7:30 PM UTC

IQVIA s AI Innovations: A Dominant Force in Healthcare and Life SciencesIQVIA (NYSE:IQV), a global leader in delivering advanced analytics, technology solutions, and clinical research services, has recently garnered significant industry recognition with its breakthrough artificial intelligence (AI) technologies across multiple fronts. The Research Triangle Park-based compan...

Economy

Navigating Innovation Amidst Market Challenges The of IQVIA AI Assistant

Published Wed, Oct 2 2024 3:47 PM UTC

In a landscape where technology and healthcare converge, IQVIA Holdings Inc. has taken a significant step forward with the introduction of its new generative AI technology, the IQVIA AI Assistant. This innovative tool aims to revolutionize how life science customers obtain and interpret essential insights, underlining IQVIA’s commitment to enhancing clinical research and h...

Business Update

IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group

Published Thu, Jul 11 2024 2:56 PM UTC

IQVIA Leads the Way in Medical Affairs and Regulatory Operations, According to Independent Research Firm RESEARCH TRIANGLE PARK, N.C. - IQVIA (NYSE:IQV), a global healthcare intelligence company, has once again demonstrated its industry leadership by being recognized as a Leader in the Life Sciences Regulatory and Medical Affairs Operations PEAK Matrix Assessment 2024 survey...

Business Update

IQVIA’s AI Mastery Steering Growth and Innovation in a Contracting Market

Published Tue, Jun 25 2024 12:47 PM UTC

IQVIA s AI Triumph: Navigating Growth Amidst Industry Contraction In a significant development for the life sciences industry, IQVIA Holdings Inc. (NYSE:IQV) has earned the Best Use of Artificial Intelligence in Healthcare accolade at the 8th Annual MedTech Breakthrough Awards for its SmartSolve Enterprise Quality Management System (eQMS). This recognition underscores IQVIA ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 33.30
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 2.73
Price to Sales (Expected) -
Price to Book 7.16
PEG (TTM) 3.28

Financial Strength Current
Quick Ratio 0.35
Working Capital Ratio 1.03
Leverage Ratio (MRQ) 3.69
Total Debt to Equity 2.49
Interest Coverage (TTM) 4.69
Debt Coverage (TTM) 0.23

Per Share Current
Earnings (TTM) 8.04 $
Revenues (TTM) 97.95 $
Cash Flow (TTM) 1.22 $
Cash 12.39 $
Book Value 37.39 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 178,839
Net Income per Employee (TTM) 14,914
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.57

Profitability Ratios Current
Gross Margin (MRQ) 32.64 %
Operating Margin (MRQ) 12.38 %
Net Margin (MRQ) 6.62 %
Net Cash Flow Margin (MRQ) -0.79 %
Effective Tax Rate (TTM) 15.66 %

Management Effectiveness Current
Return On Assets (TTM) 4.72 %
Return On Investment (TTM) 5.95 %
Return On Equity (TTM) 22.15 %
Dividend Yield -
Pay out Ratio (TTM) -



Iqvia Holdings Inc's Segments
Americas    96.92 % of total Revenue
Europe and Africa    32.64 % of total Revenue
Asia-Pacific    19.56 % of total Revenue
Commercial Solutions    43.19 % of total Revenue
Commercial Solutions Americas    20.62 % of total Revenue
Commercial Solutions Europe and Africa    16.57 % of total Revenue
Commercial Solutions Asia-Pacific    5.06 % of total Revenue
Research Development Solutions    57.75 % of total Revenue
Research Development Solutions Americas    27.17 % of total Revenue
Research Development Solutions Europe and Africa    16.07 % of total Revenue
Research Development Solutions Asia-Pacific    14.5 % of total Revenue
Research and Development Solutions    119.78 % of total Revenue
EMEA    66.59 % of total Revenue
Asia Pacific    41.72 % of total Revenue
Technology and Analytics Solutions    85.45 % of total Revenue

  Iqvia Holdings Inc Outlook

On February 6 2025 the Iqvia Holdings Inc provided following guidance

nnIQVIA Holdings Inc. Reports Q4 and Full-Year 2024 Financial Results; Reiterates 2025 Projectionsnn

Research Triangle Park, N.C. – February 6, 2025 – IQVIA Holdings Inc. (NYSE: IQV), a premier global provider of advanced clinical research services, commercial insights, and healthcare analytical tools in the life sciences sector, announced its financial outcomes for the fourth quarter and the complete year of 2024.

Ari Bousbib, the Chairman and CEO of IQVIA, expressed confidence in the company’s performance, stating, We are pleased to report strong results for the fourth quarter, marking a successful conclusion to 2024. He highlighted that revenue from Research and Development Soluti...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.